Skip to main content
Fig. 10 | Stem Cell Research & Therapy

Fig. 10

From: Intra-carotid arterial transfusion of circulatory-derived autologous endothelial progenitor cells in rodent after ischemic stroke—evaluating the impact of therapeutic time points on prognostic outcomes

Fig. 10

The underlying proposed mechanism of peripheral blood-derived endothelial progenitor cell (EPC) (i.e., CD34+ cells) therapy for improving the outcomes in patients or rodents after acute ischemic stroke. VEGF = vascular endothelial growth factors; NO = nitric oxide

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512